MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

    H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…
  • 2018 International Congress

    The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

    A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)

    Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…
  • 2018 International Congress

    Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease

    L. Robak, R. Du, B. Yuan, S. Gu, Z. Akdemir, J. Jankovic, J. Lupski, J. Shulman (Houston, TX, USA)

    Objective: To determine whether whole exome sequencing (WES) plus chromosomal microarray analysis (CMA) yield a genetic etiology in a cohort of 110 individuals with familial…
  • 2018 International Congress

    Relationship between cyclooxygenase-2 gene polymorphisms and Parkinson’s disease susceptibility in Chinese Han population

    M. Ye, Y. Yao, H. Gao (Nanjing, China)

    Objective: To investigate relationship between the cyclooxygenase-2 (COX-2) gene promoter region (rs20417, rs689466, rs689465) and 3'untranslated region (rs5275) polymorphisms with Parkinson’s disease (PD) susceptibility in…
  • 2018 International Congress

    Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance of Anti Parkinson’s Therapy

    N. Verma (Baddi, India)

    Objective: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than 7 million people worldwide. However, treatment outcome in many patients…
  • 2018 International Congress

    Decreased interhemispheric homotopic connectivity in Parkinson’s disease patients with freezing of gait: A resting state fMRI study

    L. Li, Y. Yuan, K. Zhang (Nanjing, China)

    Objective: Freezing of gait is a common complaint in patients with Parkinson’s disease (PD). However, the neural bases of freezing of gait in PD remain…
  • 2018 International Congress

    The role of exposure to pesticides in the etiology of Parkinson’s disease: F-DOPA positron emission tomography study

    R. Djaldetti, A. Steinmetz, A. Rigbi, Y. Roditi, L. Greenbaum, M. Lorberboym (Petah Tiqva, Israel)

    Objective: To examine the pattern of ligand uptake on F-DOPA PET in patients with PD who were exposed or not exposed to pesticides and examine…
  • 2018 International Congress

    Does the Basal Ganglia Dysfunction Affect Pisa Syndrome in Parkinson’s Disease?

    Y.E. Huh, W-H. Chung, J. Youn, J.H. Ahn, J.W. Cho (Seongnam, Republic of Korea)

    Objective: We elucidated whether and how asymmetric basal ganglia dysfunction is associated with the generation of Pisa syndrome (PS) in Parkinson’s disease (PD). To assess…
  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

    N. Barad, C. Sankhla (Mumbai, India)

    Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…
  • « Previous Page
  • 1
  • …
  • 223
  • 224
  • 225
  • 226
  • 227
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley